Popular Trials
Popular Filters
Frequently Asked Questions
Introduction to parkinsons
What are the top hospitals conducting parkinsons research?
While there are numerous hospitals conducting clinical trials for [Parkinson's disease](https://www.withpower.com/clinical-trials/parkinson's-disease), one institution in Augusta, Georgia is making notable strides. The Charlie Norwood VA Medical Center may have only one active trial for Parkinson's at the moment and has yet to record any completed studies on this condition. However, its dedication to serving veterans with Parkinson's cannot be underestimated. Augusta itself holds a unique significance in the realm of medical history as it was here that Dr. James Parkinson first described the disease back in 1817. Today, with ongoing research and advancements in treatment options, hospitals like Charlie Norwood VA Medical Center play an essential role in improving the lives of those affected by this neurodegenerative disorder. By participating in clinical trials, patients can access innovative therapies while contributing to scientific knowledge and potentially shaping the future of Parkinson's care worldwide
Which are the best cities for parkinsons clinical trials?
When it comes to Parkinson's clinical trials, Augusta, Georgia emerges as a top city for research. With one active trial currently underway, Augusta focuses on exploring treatments such as the Group 2 ? Niacinamide Arm and others. As a hub for cutting-edge medical research in this field, Augusta offers individuals with Parkinson's disease access to potential breakthroughs that may improve their quality of life and advance our understanding of this complex condition.
Which are the top treatments for parkinsons being explored in clinical trials?
In the realm of [Parkinson's disease](https://www.withpower.com/clinical-trials/parkinson's-disease), clinical trials are paving the way for groundbreaking treatment options. One prominent contender is levodopa-carbidopa intestinal gel, which has shown promising results in ongoing trials. Another frontrunner is deep brain stimulation (DBS), a neurosurgical procedure that delivers electrical impulses to targeted areas of the brain to alleviate symptoms. Additionally, gene therapy approaches like AAV2-Neurturin and GDNF hold significant potential as they aim to promote neuroprotection and enhance dopamine production. With researchers tirelessly exploring these innovative treatments, there is renewed hope for individuals living with Parkinson's disease worldwide.
What are the most recent clinical trials for parkinsons?
Exciting advancements are being made in the field of [Parkinson's disease](https://www.withpower.com/clinical-trials/parkinson's-disease) research, with several recent clinical trials offering hope for improved treatments. One noteworthy trial focuses on a new medication that shows promise in alleviating symptoms and slowing the progression of the disease. Additionally, another study examines the effectiveness of a non-invasive brain stimulation technique as a potential therapy option. Furthermore, researchers are exploring innovative approaches such as stem cell therapies to investigate their ability to restore lost function in Parkinson's patients. These ongoing trials provide optimism for individuals living with Parkinson's and offer prospects for enhanced care and management of this complex neurological disorder.
What parkinsons clinical trials were recently completed?
Recently completed clinical trials for [Parkinson's disease](https://www.withpower.com/clinical-trials/parkinson's-disease) have made significant strides in advancing the understanding and treatment of this complex condition. One notable trial was conducted by The Michael J. Fox Foundation, focusing on a promising therapy called UCB0599. Another study sponsored by Northwestern University explored the potential benefits of amantadine extended-release capsules as a treatment option. These recent advancements underscore the dedication of researchers in their pursuit to improve outcomes and quality of life for individuals living with Parkinson's disease.